• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The decision to stop or continue ADHD medication during breastfeeding and pregnancy is challenging for women with the condition. There aren't many studies on how exposure to ADHD for a long time could affect the pregnant fetus.

A study recently published in Molecular Psychiatry shows that children exposed to ADHD medication during the uterus do not develop neurological disorders like hearing loss or impaired vision, febrile seizures, or IQ impairment. The authors acknowledge the need for more high-quality research.

Risk/Benefit Analysis

Women who are pregnant and taking ADHD medications must weigh the advantages of using them against the risks to the foetus. Doctors don't have enough data to give clear advice but they can provide information on risks and benefits to aid pregnant women in making an informed decision.

A study published in Molecular Psychiatry found that women who used adhd medication pregnancy [new content from Telegra] medications in early pregnancy did not have an increased risk of fetal cardiac malformations or major structural birth defects. Researchers conducted a massive population-based study of case control to assess the frequency of structural defects that were major in infants who were born to mothers who took stimulants during pregnancy. Clinical geneticists, pediatric cardiologists and other experts looked over the cases to confirm that the classification was accurate and to reduce any bias.

The study conducted by the researchers was not without limitations. Researchers were unable, in the first place to differentiate the effects of the medication from the disorder. This makes it difficult to know whether the small associations observed in the groups that were exposed result from medication use or the confounding effect of comorbidities. Researchers also did not look at long-term outcomes for offspring.

The study did show that babies whose mothers had taken adhd medication intuniv medication during pregnancy were at a more risk of being admitted to the neonatal intensive care unit (NICU) than those who were born without any medication or had stopped their medications before or during pregnancy. This was due to central nervous system disorders. The increased risk of admission was not affected by the stimulant medication used during pregnancy.

Women who can prescribe adhd medication were taking stimulant ADHD medications during pregnancy also had a higher chance of having to have caesarean sections or one whose baby scored low on the Apgar scale (less than 7). These increases appeared to be independent of the type of medication taken during pregnancy.

Researchers suggest that the small risks posed by the use of adhd sleep medication list medications during early pregnancies may be offset by the greater benefits to both baby and mother of continued treatment for the woman's disorder. Physicians should discuss the issue with their patients and, where possible, help them develop strategies for improving their coping skills that can lessen the impact of her disorder on her daily functioning and relationships.

Medication Interactions

As more women than ever before are being diagnosed with ADHD and treated with medication, the dilemma of whether to continue or end treatment during pregnancy is a question that more and more physicians have to face. These decisions are often taken without clear and authoritative evidence. Instead, doctors must consider their own expertise in conjunction with the experiences of other doctors, and the research that has been conducted on the subject.

The issue of risk to the infant can be difficult to determine. Many of the studies on this subject are based on observational evidence instead of controlled research and their conclusions are often contradictory. Most studies focus on live-births, which could underestimate the severity of teratogenic effects which can cause abortions or terminations of pregnancy. The study that is discussed in this journal club addresses these limitations by analyzing data on live and deceased births.

The conclusion The conclusion: While some studies have shown a positive association between ADHD medications and the possibility of certain birth defects, others have found no connection and the majority of studies have a neutral or slight negative effect. In the end an accurate risk-benefit analysis must be done in each instance.

For a lot of women with ADHD and ADD, the decision to stop medication can be difficult, if not impossible. In a recent article in the Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can cause depression and feelings of being isolated. Furthermore, a loss of medication can interfere with the ability to perform jobs and drive safely that are crucial aspects of daily life for many people with ADHD.

She suggests that women who aren't sure whether to continue taking medication or stop it due to their pregnancy educate family members, colleagues, and their friends about the condition, the effects on daily functioning, and the advantages of staying on the current treatment regimen. Educating them can also make the woman feel more comfortable when she is struggling with her decision. It is important to remember that some drugs can be absorbed through the placenta so if the patient decides to stop taking her ADHD medication during pregnancy and breastfeeding, she must be aware of the possibility that traces of the medication could be transferred to the infant.

Risk of Birth Defects

As the use and misuse of ADHD medications to treat the symptoms of attention deficit disorder hyperactivity disorder (ADHD), increases, so does concern about the possible effects of the drugs on fetuses. A recent study published in the journal Molecular Psychiatry adds to the existing knowledge about this subject. Researchers used two huge data sets to examine more than 4.3 million pregnancy and determine whether stimulant medications increased the risk of birth defects. While the overall risk remains low, the researchers discovered that the first-trimester exposure to ADHD medicines was associated with an increased risk of certain heart defects, such as ventriculoseptal defect (VSD).

The authors of the study didn't find any association between early use of medication and congenital anomalies like facial deformities or club feet. The results are in agreement with previous studies which showed the existence of a slight, but significant increase in cardiac malformations for women who started taking ADHD medication prior to the time of the birth of their child. This risk increased during the latter half of pregnancy when a large number of women decided to stop taking their medication.

Women who used ADHD medications in the first trimester of their pregnancy were also more likely to experience a caesarean section, a low Apgar score following delivery, and a baby who required breathing assistance at birth. However, the authors of the study were not able to eliminate selection bias by restricting the study to women who didn't have any other medical issues that could have contributed to the findings.

The researchers hope that their research will help inform the clinical decisions of physicians who see pregnant women. The researchers recommend that while discussing benefits and risks are important, the choice regarding whether or not to stop medication should be made in light of the severity of each woman's ADHD symptoms and the needs of the woman.

The authors caution that, while stopping the medication is a possibility to consider, it is not recommended because of the high incidence of depression and other mental problems for women who are pregnant or recently gave birth. Furthermore, research suggests that women who decide to stop taking their medications are more likely to have difficulties adjusting to life without them following the birth of their baby.

Nursing

It can be overwhelming to become a mother. Women with ADHD are often faced with a number of difficulties when they must deal with their symptoms, attend doctor appointments, prepare for the birth of a baby and adjust to new routines. This is why many women choose to continue taking their ADHD medications throughout the course of pregnancy.

The majority of stimulant medicines are absorbed by breast milk in very small amounts, so the risk for nursing infant is very low. The rate of medication exposure will differ based on dosage the medication is administered, its frequency and the time of day. In addition, individual medications enter the body of the baby differently through the gastrointestinal tract and breast milk and the impact of this on a newborn isn't yet fully known.

Because of the lack of research, some doctors might be tempted to stop taking stimulant medication during a woman's pregnancy. This is a difficult decision for the mother, who must weigh the advantages of taking her medication as well as the risk to the foetus. As long as more information is available, doctors may inquire about pregnant patients whether they have an history of ADHD or if they intend to take medication during the perinatal stage.

Numerous studies have proven that women can continue taking their ADHD medication without risk during pregnancy and while breast-feeding. In the end, an increasing number of patients opt to do this and in consultation with their physician, they have discovered that the benefits of maintaining their current medication far outweigh any potential risks.

Women who suffer from ADHD who are planning to nurse should seek the advice of an expert psychiatrist prior to becoming pregnant. They should review their medications with their doctor and discuss the advantages and disadvantages of continuing treatment, including non-pharmacological strategies. Psychoeducation is also required to help pregnant women with ADHD recognize the signs and underlying disorder. They should also learn about treatment options and build strategies for coping. This should involve a multidisciplinary approach with the GP doctors, obstetricians and psychiatrists. Pregnancy counseling should consist of a discussion of a treatment plan for the mother and child, as well as monitoring for indicators of deterioration, and, if needed, adjustments to the medication regimen.